NM_001099404.2:c.3206C>T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 5P and 4B. PM1PM2PP2BS1
The NM_001099404.2(SCN5A):c.3206C>T(p.Thr1069Met) variant causes a missense change. The variant allele was found at a frequency of 0.000043 in 1,606,186 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001099404.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.3206C>T | p.Thr1069Met | missense_variant | Exon 17 of 28 | ENST00000413689.6 | NP_001092874.1 | |
SCN5A | NM_000335.5 | c.3206C>T | p.Thr1069Met | missense_variant | Exon 17 of 28 | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.3206C>T | p.Thr1069Met | missense_variant | Exon 17 of 28 | 5 | NM_001099404.2 | ENSP00000410257.1 | ||
SCN5A | ENST00000423572.7 | c.3206C>T | p.Thr1069Met | missense_variant | Exon 17 of 28 | 1 | NM_000335.5 | ENSP00000398266.2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152186Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000150 AC: 37AN: 246942Hom.: 0 AF XY: 0.000157 AC XY: 21AN XY: 133878
GnomAD4 exome AF: 0.0000440 AC: 64AN: 1453882Hom.: 0 Cov.: 30 AF XY: 0.0000471 AC XY: 34AN XY: 721504
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152304Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74464
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. p.Thr1069Met (T1069M; c.3206C>T) in exon 17 of the SCN5A gene (NM_198056.2) We do not believe there is enough evidence to call this variant “disease-causing” at this time. It may instead be a rare benign variant that is more common in individuals with Hispanic ancestry. It has only been published in one “case” of LQTS, and this individual was also Hispanic. Furthermore, there is no phenotype data available for that patient, and so we cannot confirm that the individual actually had LQTS. This variant has previously been reported in just one Hispanic individual (the ethnicity is important) who had genetic testing for LQTS through the Familion laboratory (Tester et al. 2005; Kapplinger et al. 2009, Kapa et al. 2009). There is no phenotype information available for this individual, and we cannot assume that they have a confirmed clinical diagnosis of LQTS. Of note, genetic testing for the 2500 Familion cases reported by Kapplinger et al (2009) have an unusually low yield of 36% (vs. 70% in cohorts with a firm diagnoses of long QT syndrome), which suggests that not all of these patients have a firm diagnosis. Also, these papers have a lack of clarity regarding which variants were seen with another pathogenic variant (9% of the cohort had multiple variants). This is a non-conservative amino acid change, resulting in the replacement of a polar Threonine with a nonpolar Methionine in interdomain linker II-III. The Threonine at this location is NOT conserved across vertebrate species, and in fact the default amino acid is a Methionine in alligators and in 2 species of bird. Variation at nearby residues (+/- 10 amino acids) has NOT been associated with LQTS except for at residue Ser1079, which may argue against the functional importance of this region of the protein: (HGMD professional version as of January 17, 2014; and GeneDx report). This site in the protein is also not conserved across paralogue proteins: http://cardiodb.org/Paralogue_Annotation/residue.php?gene=SCN5A&position=1069. In silico analysis with PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/) predicts the variant to be “Probably Damaging” with a score of 0.993. In total the variant has been seen in 15 published controls or individuals from publicly available population datasets. The p.Thr1069Met variant is overrepresented among “Latino” individuals in the ExAC dataset, which currently includes variant calls on ~60,000 individuals of multiple ethnic backgrounds (Latino, European (non-Finnish), Finnish, South Asian, African & East Asian). It is present in 11 out of 5,749 Latinos in that database, which is an allele frequency of 0.1%. This estimates that ~2 out of every 1000 Latinos would carry the variant, which is a higher incidence than the overall estimated incidence of LQTS (1 in 2500 people). This variant is otherwise present in only 1 South Asian individual (out of 6,634) and 2 Caucasian individuals (out of 35,669). These individuals took part in a range of disease-specific and population genetic studies, and the curators made an effort to exclude individuals with severe pediatric diseases. There is only one individual with this variant listed in 1000 Genomes (http://browser.1000genomes.org/index.htm) as of 3/26/2015, and this individual also has Mexican ancestry. The variant was not observed in published controls, including 1300 from Kapplinger et al. 2009 (143 of them Hispanic). There is also no variation at this residue listed in the NHLBI Exome Sequencing Project dataset (http://evs.gs.washington.edu/EVS/), which currently includes variant calls on ~4300 Caucasian and ~2200 African American individuals who are NOT ethnicity-matched to our patient (who ha -
Variant summary: SCN5A c.3206C>T (p.Thr1069Met) results in a non-conservative amino acid change located in the Sodium ion transport-associated domain of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00015 in 246942 control chromosomes, predominantly at a frequency of 0.00093 within the Latino subpopulation in the gnomAD database. The observed variant frequency within Latino control individuals in the gnomAD database is approximately 9 fold of the estimated maximal expected allele frequency for a pathogenic variant in SCN5A causing Arrhythmia phenotype (0.0001), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Latino origin. c.3206C>T has been reported in the literature in individuals affected with Arrhythmia. These report(s) do not provide unequivocal conclusions about association of the variant with Arrhythmia.To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 31737537). ClinVar contains an entry for this variant (Variation ID: 67782). Based on the evidence outlined above, the variant was classified as likely benign. -
not provided Uncertain:1Benign:1
- -
Reported in individuals with LQTS or referred for LQTS genetic testing and in one infant with sudden unexplained death who also harbored additional variants in four other cardiac genes (PMID: 15840476, 19841300, 19716085, 21185501, 25904541, 27435932); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 19716085, 27435932, 31737537, 16731473, 19841300, 21185501, 25904541, 28150151, 22581653, 32893267, 15840476, 28988457) -
Brugada syndrome 1 Uncertain:1
- -
SUDDEN INFANT DEATH SYNDROME;C1832680:Dilated cardiomyopathy 1E;C1837845:Sick sinus syndrome 1;C1859062:Long QT syndrome 3;C1879286:Progressive familial heart block, type 1A;C2751898:Ventricular fibrillation, paroxysmal familial, type 1;C3151464:Atrial fibrillation, familial, 10;C4551804:Brugada syndrome 1 Uncertain:1
- -
Cardiac arrhythmia Uncertain:1
This missense variant replaces threonine with methionine at codon 1069 of the SCN5A protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals suspected of having long QT syndrome (PMID: 25904541). This variant has been identified in 37/246942 chromosomes (32/34364 Latino chromosomes) in the general population by the Genome Aggregation Database (gnomAD). The relatively high frequency of this variant in the general population suggests that this variant is unlikely to be disease-causing. However, additional studies are necessary to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Congenital long QT syndrome Other:1
This variant has been reported as associated with Long QT syndrome in the following publications (PMID:15840476;PMID:19716085;PMID:19841300). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at